- Article metrics
- Last updated: Sat, 18 Apr 2026 19:02:08 Z
A therapeutic antibody targeting annexin-A1 inhibits cancer cell growth in vitro and in vivo
Access & Citations
-
- 18k
- Article Accesses
-
- 28
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
Online attention
- 8 tweeters
- 1 blogs
- 10 news outlets
- 32 Mendeley
This article is in the 97th percentile (ranked 10,833rd) of the 428,308 tracked articles of a similar age in all journals and the 98th percentile (ranked 1st) of the 57 tracked articles of a similar age in Oncogene
View more on Altmetric
Altmetric calculates a score based on the online attention an article receives. The donut visual summarises attention from different sources; a breakdown is shown in the legend. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Mentions in news and blogs
-
Targeting annexin-A1 can halt cancer cell growth
Mirage News -
Targeting annexin-A1 can halt cancer cell growth
EurekAlert! -
MIL-OSI UK Cities: Targeting annexin-A1 can halt cancer cell growth
Foreign Affairs New Zealand -
Anglia Ruskin University: Targeting Annexin-A1 Can Halt Cancer Cell Growth (1/20/24)
Targeted News Service -
Annexin-A1 targeted therapy beats several cancers
The Medical News -
Annexin-A1 targeted therapy beats several cancers
news-medical.net
This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.